AtoGen Co. Ltd clinical trials

Acquired by Yuhan Corporation, 2022 · source ↗

The registry lists 1 studies whose lead sponsor is AtoGen Co. Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 9, 2023.

Before and after it joined Yuhan Corporation

First submitted before AtoGen Co. Ltd became part of Yuhan Corporation: 0
First submitted after AtoGen Co. Ltd became part of Yuhan Corporation: 0
Unclear, or no submission date: 1

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Status unknown: 1

Phase

Phase 1: 1

Where

Australia: 1

Registry sponsor names on this page

AtoGen Co. Ltd1 study

Something wrong with this grouping? Tell us on the Yuhan Corporation page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Yuhan Corporation studies →

Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy WomenStatus unknownNCT05587283Phase 1
Sponsor listed in the registry: AtoGen Co. Ltd · Unclear whether first submitted before or after AtoGen Co. Ltd became part of Yuhan Corporation